IMF Staff Country Reports

Denmark: Selected Issues

September 13, 2024

Download PDF More Formats on IMF eLibrary Order a Print Copy
More formats on IMF eLibrary Order a Print Copy

Preview Citation

Format: Chicago

International Monetary Fund. European Dept. "Denmark: Selected Issues", IMF Staff Country Reports 2024, 293 (2024), accessed October 19, 2024, https://doi.org/10.5089/9798400288227.002

Export Citation

  • ProCite
  • RefWorks
  • Reference Manager
  • BibTex
  • Zotero
  • EndNote

Summary

This Selected Issues paper discusses the macroeconomic impact of the pharmaceutical sector. The analysis focuses on Novo Nordisk, the leading pharmaceutical company in Denmark, and its productivity impact on the rest of the economy. Empirical evidence suggests only weak correlations between productivity shocks at Novo Nordisk and overall economic growth, as well as between Novo Nordisk’s productivity and that of other firms. The findings suggest there is limited risk that Denmark’s booming pharmaceutical company would become its “Nokia.” Although the pharmaceutical sector will be a key driver of growth, most of its production occurs overseas under Danish ownership. As a result, its linkages with the rest of the domestic economy, in terms of employment and supply chains, are somewhat limited. The empirical results also indicate limited spillover effects through productivity channels. However, the empirical results may underestimate the influence of Novo Nordisk due to limited data.

Subject: Covered bonds, Financial institutions, Financial sector policy and analysis, Labor productivity, Nonbank financial institutions, Production, Productivity, Systemic risk assessment

Keywords: Covered bond bond market, Covered bonds, E. policy option, Energy firm, Global, Labor productivity, Mitigating factor, Nonbank financial institutions, Policy consideration, Productivity, Productivity shock, Shocks to Novo Nordisk, Systemic risk assessment

Publication Details

You May Also Be Interested In...

Ukraine: Fifth Review Under the Extended Arrangement Under the Extended Fund Facility, Requests for Waivers of Applicability of Performance Criteria, Modification of Performance Criterion, Rephasing of Access, and Financing Assurances Review-Press Release; Staff Report; and Statement by the Executive Director for Ukraine

October 18, 2024

Republic of Kazakhstan: Financial Sector Assessment Program-Technical Note on Astana International Financial Center and the Kazakhstan Financial System

October 17, 2024

Republic of Türkiye: 2024 Article IV Consultation-Press Release; Staff Report; and Statement by the Executive Director for the Republic of Türkiye

October 11, 2024

What Can Artificial Intelligence Do for Stagnant Productivity in Latin America and the Caribbean?

October 11, 2024